Related Experiment Video
Updated: Dec 14, 2025
A Novel In Vitro Model of Blast Traumatic Brain Injury
Published on: December 21, 2018
Current advances in in vitro models of central nervous system trauma
Anton Omelchenko1,2, Nisha K Singh1,3, Bonnie L Firestein1
1Department of Cell Biology and Neuroscience; Rutgers, The State University of New Jersey, 604 Allison Road, Piscataway, NJ 08854-8082.
Abstract:
CNS trauma is a prominent cause of mortality and morbidity, and although much effort has focused on developing treatments for CNS trauma-related pathologies, little progress has been made. Pre-clinical models of TBI and SCI suffer from significant drawbacks, which result in substantial failures during clinical translation of promising pre-clinical therapies. Here, we review recent advances made in the development of in vitro models of CNS trauma, the promises and drawbacks of current in vitro CNS injury models, and the attributes necessary for future models to accurately mimic the trauma microenvironment and facilitate CNS trauma drug discovery. The goal is to provide insight for the development of future CNS injury models and to aid researchers in selecting effective models for pre-clinical research of trauma therapeutics.
Insights
Developing better in vitro models for central nervous system (CNS) trauma is crucial. Current pre-clinical models fail in clinical translation, highlighting the need for improved CNS injury models for effective drug discovery.
Area of Science:
- Neuroscience
- Biomedical Engineering
- Pharmacology
Background:
- Central nervous system (CNS) trauma, including traumatic brain injury (TBI) and spinal cord injury (SCI), leads to significant mortality and morbidity.
- Despite extensive research, developing effective treatments for CNS trauma has seen limited success, largely due to limitations in pre-clinical models.
Purpose of the Study:
- To review advancements in in vitro models for CNS trauma.
- To critically evaluate the strengths and weaknesses of existing in vitro CNS injury models.
- To outline essential characteristics for future models to improve CNS trauma drug discovery.
Main Methods:
- Literature review of recent developments in in vitro CNS trauma modeling.
- Analysis of the advantages and disadvantages of current in vitro CNS injury models.
- Identification of key features required for next-generation CNS trauma models.
Main Results:
- Current in vitro models face challenges in accurately replicating the complex CNS trauma microenvironment.
- Significant discrepancies exist between pre-clinical findings and clinical outcomes, indicating a translational gap.
- There is a clear need for more sophisticated in vitro models that better mimic in vivo conditions.
Conclusions:
- Improved in vitro models are essential to overcome the limitations of current pre-clinical approaches for CNS trauma.
- Future models must accurately recapitulate the trauma microenvironment to enhance the reliability of drug discovery.
- This review provides insights for developing and selecting appropriate models for CNS trauma therapeutics research.
